Nalaganje...
Levamisole as an Adjuvant to Short-Course Therapy in Newly Diagnosed Pulmonary Tuberculosis Patients
BACKGROUND: The estimated incidence and prevalence of tuberculosis in India are 2.1 and 2.6 million cases respectively. Immunotherapy may shorten tuberculosis treatments and improve the immunity of individuals as well. Hence we study the efficacy of levamisole (LVM) (immunomodulator) as an adjuvant...
Shranjeno v:
| izdano v: | Adv Biomed Res |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Medknow Publications & Media Pvt Ltd
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5385702/ https://ncbi.nlm.nih.gov/pubmed/28516071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2277-9175.203162 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|